nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Topoisomerase Inhibitors—Mitoxantrone—prostate cancer	0.172	0.49	CiPCiCtD
Etoposide—urinary bladder cancer—prostate cancer	0.122	0.557	CtDrD
Etoposide—testicular cancer—prostate cancer	0.0968	0.443	CtDrD
Etoposide—Topoisomerase Inhibitors—Epirubicin—prostate cancer	0.0928	0.265	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Doxorubicin—prostate cancer	0.0858	0.245	CiPCiCtD
Etoposide—GSTT1—prostate cancer	0.0375	0.248	CbGaD
Etoposide—GSTP1—prostate cancer	0.0296	0.196	CbGaD
Etoposide—TOP2A—prostate cancer	0.028	0.185	CbGaD
Etoposide—CYP3A5—prostate cancer	0.0221	0.146	CbGaD
Etoposide—CYP2E1—prostate cancer	0.0152	0.1	CbGaD
Etoposide—ABCC10—Estradiol—prostate cancer	0.00996	0.0571	CbGbCtD
Etoposide—CYP3A4—prostate cancer	0.00957	0.0632	CbGaD
Etoposide—PTGS2—prostate cancer	0.00937	0.0619	CbGaD
Etoposide—ABCC1—Abiraterone—prostate cancer	0.00926	0.0531	CbGbCtD
Etoposide—TOP2A—Mitoxantrone—prostate cancer	0.00718	0.0412	CbGbCtD
Etoposide—ABCC3—Conjugated Estrogens—prostate cancer	0.00713	0.0409	CbGbCtD
Etoposide—ABCC10—Docetaxel—prostate cancer	0.00595	0.0341	CbGbCtD
Etoposide—TOP2A—Epirubicin—prostate cancer	0.00581	0.0333	CbGbCtD
Etoposide—ABCC6—Doxorubicin—prostate cancer	0.0058	0.0333	CbGbCtD
Etoposide—UGT1A1—Estradiol—prostate cancer	0.00468	0.0268	CbGbCtD
Etoposide—ABCG2—Cabazitaxel—prostate cancer	0.00458	0.0263	CbGbCtD
Etoposide—ABCG2—Estrone—prostate cancer	0.00448	0.0257	CbGbCtD
Etoposide—ABCC10—Doxorubicin—prostate cancer	0.00443	0.0254	CbGbCtD
Etoposide—ABCC2—Ethinyl Estradiol—prostate cancer	0.00442	0.0253	CbGbCtD
Etoposide—ABCC1—Conjugated Estrogens—prostate cancer	0.00438	0.0251	CbGbCtD
Etoposide—CYP2C8—Nilutamide—prostate cancer	0.00398	0.0228	CbGbCtD
Etoposide—ABCC1—Mitoxantrone—prostate cancer	0.00398	0.0228	CbGbCtD
Etoposide—CYP3A5—Flutamide—prostate cancer	0.00343	0.0197	CbGbCtD
Etoposide—CYP2C8—Abiraterone—prostate cancer	0.0033	0.0189	CbGbCtD
Etoposide—ABCC2—Conjugated Estrogens—prostate cancer	0.00324	0.0186	CbGbCtD
Etoposide—ABCC1—Epirubicin—prostate cancer	0.00322	0.0185	CbGbCtD
Etoposide—CYP2E1—Estrone—prostate cancer	0.00319	0.0183	CbGbCtD
Etoposide—TOP2A—Doxorubicin—prostate cancer	0.00309	0.0177	CbGbCtD
Etoposide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00307	0.0176	CbGbCtD
Etoposide—ABCG2—Conjugated Estrogens—prostate cancer	0.00293	0.0168	CbGbCtD
Etoposide—ABCC3—Doxorubicin—prostate cancer	0.00279	0.016	CbGbCtD
Etoposide—ABCG2—Mitoxantrone—prostate cancer	0.00266	0.0153	CbGbCtD
Etoposide—ABCG2—Estradiol—prostate cancer	0.00257	0.0148	CbGbCtD
Etoposide—CYP1A2—Flutamide—prostate cancer	0.00255	0.0147	CbGbCtD
Etoposide—CYP3A5—Cabazitaxel—prostate cancer	0.00254	0.0146	CbGbCtD
Etoposide—ABCB1—Estramustine—prostate cancer	0.00251	0.0144	CbGbCtD
Etoposide—CYP3A5—Estrone—prostate cancer	0.00248	0.0142	CbGbCtD
Etoposide—CYP2C8—Cabazitaxel—prostate cancer	0.00244	0.014	CbGbCtD
Etoposide—ABCC1—Docetaxel—prostate cancer	0.0023	0.0132	CbGbCtD
Etoposide—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00213	0.0122	CbGbCtD
Etoposide—CYP2E1—Mitoxantrone—prostate cancer	0.0019	0.0109	CbGbCtD
Etoposide—CYP1A2—Estrone—prostate cancer	0.00185	0.0106	CbGbCtD
Etoposide—ABCC1—Doxorubicin—prostate cancer	0.00171	0.00982	CbGbCtD
Etoposide—ABCC2—Docetaxel—prostate cancer	0.0017	0.00975	CbGbCtD
Etoposide—GSTT1—urine—prostate cancer	0.00168	0.0979	CbGeAlD
Etoposide—ABCB1—Cabazitaxel—prostate cancer	0.00165	0.00948	CbGbCtD
Etoposide—CYP3A4—Bicalutamide—prostate cancer	0.00162	0.00926	CbGbCtD
Etoposide—ABCB1—Estrone—prostate cancer	0.00162	0.00926	CbGbCtD
Etoposide—ABCG2—Docetaxel—prostate cancer	0.00154	0.00882	CbGbCtD
Etoposide—CYP3A4—Estramustine—prostate cancer	0.0015	0.00861	CbGbCtD
Etoposide—ABCB1—Ethinyl Estradiol—prostate cancer	0.00144	0.00826	CbGbCtD
Etoposide—CYP3A5—Estradiol—prostate cancer	0.00143	0.00817	CbGbCtD
Etoposide—CYP2C8—Estradiol—prostate cancer	0.00137	0.00786	CbGbCtD
Etoposide—CYP3A4—Abiraterone—prostate cancer	0.00134	0.00768	CbGbCtD
Etoposide—CYP3A4—Flutamide—prostate cancer	0.00134	0.00768	CbGbCtD
Etoposide—ABCC2—Doxorubicin—prostate cancer	0.00127	0.00727	CbGbCtD
Etoposide—CYP1A2—Conjugated Estrogens—prostate cancer	0.00121	0.00693	CbGbCtD
Etoposide—ABCG2—Doxorubicin—prostate cancer	0.00115	0.00657	CbGbCtD
Etoposide—CYP1A2—Estradiol—prostate cancer	0.00106	0.00608	CbGbCtD
Etoposide—ABCB1—Conjugated Estrogens—prostate cancer	0.00106	0.00606	CbGbCtD
Etoposide—CYP3A4—Cabazitaxel—prostate cancer	0.00099	0.00568	CbGbCtD
Etoposide—UGT1A1—urine—prostate cancer	0.000985	0.0575	CbGeAlD
Etoposide—CYP3A4—Estrone—prostate cancer	0.000968	0.00555	CbGbCtD
Etoposide—ABCB1—Mitoxantrone—prostate cancer	0.00096	0.00551	CbGbCtD
Etoposide—ABCB1—Estradiol—prostate cancer	0.000928	0.00532	CbGbCtD
Etoposide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.000862	0.00495	CbGbCtD
Etoposide—CYP3A5—Docetaxel—prostate cancer	0.000851	0.00488	CbGbCtD
Etoposide—ABCB1—Prednisone—prostate cancer	0.000798	0.00458	CbGbCtD
Etoposide—GSTP1—urine—prostate cancer	0.000774	0.0452	CbGeAlD
Etoposide—Teniposide—NCOA1—prostate cancer	0.00064	0.361	CrCbGaD
Etoposide—CYP3A4—Conjugated Estrogens—prostate cancer	0.000633	0.00363	CbGbCtD
Etoposide—GSTT1—prostate gland—prostate cancer	0.000602	0.0351	CbGeAlD
Etoposide—CYP3A4—Mitoxantrone—prostate cancer	0.000575	0.0033	CbGbCtD
Etoposide—CYP3A4—Estradiol—prostate cancer	0.000556	0.00319	CbGbCtD
Etoposide—ABCB1—Docetaxel—prostate cancer	0.000554	0.00318	CbGbCtD
Etoposide—CYP3A4—Prednisone—prostate cancer	0.000478	0.00274	CbGbCtD
Etoposide—TOP2B—prostate gland—prostate cancer	0.000444	0.0259	CbGeAlD
Etoposide—CYP1A2—urine—prostate cancer	0.000436	0.0254	CbGeAlD
Etoposide—Teniposide—NCOA3—prostate cancer	0.000432	0.244	CrCbGaD
Etoposide—ABCB1—Doxorubicin—prostate cancer	0.000413	0.00237	CbGbCtD
Etoposide—GSTT1—renal system—prostate cancer	0.00041	0.024	CbGeAlD
Etoposide—CYP2E1—urine—prostate cancer	0.000392	0.0229	CbGeAlD
Etoposide—TOP2B—seminal vesicle—prostate cancer	0.000375	0.0219	CbGeAlD
Etoposide—UGT1A1—prostate gland—prostate cancer	0.000353	0.0206	CbGeAlD
Etoposide—ABCC6—renal system—prostate cancer	0.000333	0.0194	CbGeAlD
Etoposide—CYP3A4—Docetaxel—prostate cancer	0.000332	0.0019	CbGbCtD
Etoposide—TOP2A—prostate gland—prostate cancer	0.000326	0.019	CbGeAlD
Etoposide—CYP3A4—urine—prostate cancer	0.000316	0.0184	CbGeAlD
Etoposide—TOP2B—renal system—prostate cancer	0.000302	0.0176	CbGeAlD
Etoposide—TOP2B—urethra—prostate cancer	0.000297	0.0173	CbGeAlD
Etoposide—ABCC3—prostate gland—prostate cancer	0.000279	0.0163	CbGeAlD
Etoposide—GSTP1—prostate gland—prostate cancer	0.000278	0.0162	CbGeAlD
Etoposide—ABCC10—prostate gland—prostate cancer	0.000278	0.0162	CbGeAlD
Etoposide—CYP3A4—Doxorubicin—prostate cancer	0.000248	0.00142	CbGbCtD
Etoposide—UGT1A1—renal system—prostate cancer	0.000241	0.0141	CbGeAlD
Etoposide—GSTP1—seminal vesicle—prostate cancer	0.000235	0.0137	CbGeAlD
Etoposide—ABCC10—seminal vesicle—prostate cancer	0.000235	0.0137	CbGeAlD
Etoposide—TOP2A—Docetaxel—Cabazitaxel—prostate cancer	0.000229	0.296	CbGdCrCtD
Etoposide—TOP2B—bone marrow—prostate cancer	0.000229	0.0133	CbGeAlD
Etoposide—ABCC2—prostate gland—prostate cancer	0.000223	0.013	CbGeAlD
Etoposide—GSTP1—epithelium—prostate cancer	0.000204	0.0119	CbGeAlD
Etoposide—ABCC1—prostate gland—prostate cancer	0.000196	0.0115	CbGeAlD
Etoposide—TOP2B—testis—prostate cancer	0.000195	0.0114	CbGeAlD
Etoposide—ABCC3—renal system—prostate cancer	0.00019	0.0111	CbGeAlD
Etoposide—GSTP1—renal system—prostate cancer	0.000189	0.0111	CbGeAlD
Etoposide—ABCC10—renal system—prostate cancer	0.000189	0.011	CbGeAlD
Etoposide—GSTP1—urethra—prostate cancer	0.000186	0.0109	CbGeAlD
Etoposide—ABCC10—urethra—prostate cancer	0.000186	0.0108	CbGeAlD
Etoposide—TOP2A—bone marrow—prostate cancer	0.000168	0.00981	CbGeAlD
Etoposide—ABCC1—seminal vesicle—prostate cancer	0.000166	0.00969	CbGeAlD
Etoposide—ABCG2—prostate gland—prostate cancer	0.000163	0.00949	CbGeAlD
Etoposide—TOP2A—Paclitaxel—Cabazitaxel—prostate cancer	0.000158	0.204	CbGdCrCtD
Etoposide—ABCC2—renal system—prostate cancer	0.000152	0.00887	CbGeAlD
Etoposide—CYP3A5—prostate gland—prostate cancer	0.000151	0.00881	CbGeAlD
Etoposide—Podofilox—TOP2A—prostate cancer	0.000148	0.0833	CrCbGaD
Etoposide—TOP2A—testis—prostate cancer	0.000144	0.00839	CbGeAlD
Etoposide—GSTP1—bone marrow—prostate cancer	0.000143	0.00836	CbGeAlD
Etoposide—ABCC10—bone marrow—prostate cancer	0.000143	0.00835	CbGeAlD
Etoposide—TOP2B—lymph node—prostate cancer	0.000142	0.00827	CbGeAlD
Etoposide—CYP2E1—prostate gland—prostate cancer	0.000141	0.00821	CbGeAlD
Etoposide—ABCG2—seminal vesicle—prostate cancer	0.000138	0.00803	CbGeAlD
Etoposide—PTGS1—prostate gland—prostate cancer	0.000136	0.00791	CbGeAlD
Etoposide—ABCC1—urethra—prostate cancer	0.000131	0.00767	CbGeAlD
Etoposide—PTGS2—prostate gland—prostate cancer	0.00013	0.00756	CbGeAlD
Etoposide—Teniposide—TOP2A—prostate cancer	0.000126	0.0709	CrCbGaD
Etoposide—ABCC3—testis—prostate cancer	0.000123	0.00717	CbGeAlD
Etoposide—GSTP1—testis—prostate cancer	0.000122	0.00714	CbGeAlD
Etoposide—ABCC10—testis—prostate cancer	0.000122	0.00714	CbGeAlD
Etoposide—CYP2E1—seminal vesicle—prostate cancer	0.000119	0.00695	CbGeAlD
Etoposide—PTGS1—seminal vesicle—prostate cancer	0.000115	0.00669	CbGeAlD
Etoposide—CYP2C8—renal system—prostate cancer	0.000114	0.00665	CbGeAlD
Etoposide—PTGS2—seminal vesicle—prostate cancer	0.00011	0.0064	CbGeAlD
Etoposide—ABCG2—urethra—prostate cancer	0.000109	0.00635	CbGeAlD
Etoposide—CYP1A2—renal system—prostate cancer	0.000107	0.00622	CbGeAlD
Etoposide—TOP2A—lymph node—prostate cancer	0.000104	0.00608	CbGeAlD
Etoposide—CYP3A5—renal system—prostate cancer	0.000103	0.006	CbGeAlD
Etoposide—PTGS1—epithelium—prostate cancer	9.96e-05	0.00581	CbGeAlD
Etoposide—Teniposide—CYP3A5—prostate cancer	9.91e-05	0.0559	CrCbGaD
Etoposide—ABCC2—testis—prostate cancer	9.82e-05	0.00573	CbGeAlD
Etoposide—CYP2E1—renal system—prostate cancer	9.59e-05	0.0056	CbGeAlD
Etoposide—PTGS2—epithelium—prostate cancer	9.52e-05	0.00556	CbGeAlD
Etoposide—CYP2E1—urethra—prostate cancer	9.42e-05	0.0055	CbGeAlD
Etoposide—PTGS1—renal system—prostate cancer	9.24e-05	0.00539	CbGeAlD
Etoposide—ABCC3—lymph node—prostate cancer	8.91e-05	0.0052	CbGeAlD
Etoposide—GSTP1—lymph node—prostate cancer	8.87e-05	0.00518	CbGeAlD
Etoposide—ABCC10—lymph node—prostate cancer	8.87e-05	0.00517	CbGeAlD
Etoposide—PTGS2—renal system—prostate cancer	8.83e-05	0.00516	CbGeAlD
Etoposide—Podofilox—NR3C1—prostate cancer	8.7e-05	0.0491	CrCbGaD
Etoposide—PTGS2—urethra—prostate cancer	8.68e-05	0.00506	CbGeAlD
Etoposide—ABCC1—testis—prostate cancer	8.65e-05	0.00505	CbGeAlD
Etoposide—ABCG2—bone marrow—prostate cancer	8.38e-05	0.00489	CbGeAlD
Etoposide—ABCB1—prostate gland—prostate cancer	8.02e-05	0.00468	CbGeAlD
Etoposide—Podofilox—CYP2C19—prostate cancer	7.93e-05	0.0448	CrCbGaD
Etoposide—CYP3A4—renal system—prostate cancer	7.72e-05	0.00451	CbGeAlD
Etoposide—CYP2C8—testis—prostate cancer	7.37e-05	0.0043	CbGeAlD
Etoposide—ABCG2—testis—prostate cancer	7.16e-05	0.00418	CbGeAlD
Etoposide—ABCC2—lymph node—prostate cancer	7.12e-05	0.00415	CbGeAlD
Etoposide—ABCB1—seminal vesicle—prostate cancer	6.78e-05	0.00396	CbGeAlD
Etoposide—Teniposide—CYP2C19—prostate cancer	6.74e-05	0.0381	CrCbGaD
Etoposide—PTGS2—bone marrow—prostate cancer	6.68e-05	0.0039	CbGeAlD
Etoposide—TOP2A—Paclitaxel—Docetaxel—prostate cancer	6.57e-05	0.0848	CbGdCrCtD
Etoposide—ABCC1—lymph node—prostate cancer	6.27e-05	0.00366	CbGeAlD
Etoposide—CYP2E1—testis—prostate cancer	6.2e-05	0.00362	CbGeAlD
Etoposide—PTGS1—testis—prostate cancer	5.97e-05	0.00349	CbGeAlD
Etoposide—ABCB1—epithelium—prostate cancer	5.89e-05	0.00344	CbGeAlD
Etoposide—ABCB1—renal system—prostate cancer	5.46e-05	0.00319	CbGeAlD
Etoposide—ABCB1—urethra—prostate cancer	5.37e-05	0.00313	CbGeAlD
Etoposide—ABCG2—lymph node—prostate cancer	5.19e-05	0.00303	CbGeAlD
Etoposide—Podofilox—CYP3A4—prostate cancer	5.04e-05	0.0285	CrCbGaD
Etoposide—TOP2A—Fulvestrant—Estradiol—prostate cancer	4.8e-05	0.0619	CbGdCrCtD
Etoposide—PTGS1—lymph node—prostate cancer	4.33e-05	0.00253	CbGeAlD
Etoposide—Teniposide—CYP3A4—prostate cancer	4.29e-05	0.0242	CrCbGaD
Etoposide—TOP2A—Levorphanol—Estrone—prostate cancer	4.18e-05	0.054	CbGdCrCtD
Etoposide—PTGS2—lymph node—prostate cancer	4.14e-05	0.00242	CbGeAlD
Etoposide—ABCB1—bone marrow—prostate cancer	4.13e-05	0.00241	CbGeAlD
Etoposide—ABCB1—testis—prostate cancer	3.53e-05	0.00206	CbGeAlD
Etoposide—TOP2A—Levorphanol—Estradiol—prostate cancer	3.17e-05	0.0409	CbGdCrCtD
Etoposide—TOP2A—Methyltestosterone—Ethinyl Estradiol—prostate cancer	2.89e-05	0.0373	CbGdCrCtD
Etoposide—ABCB1—lymph node—prostate cancer	2.56e-05	0.00149	CbGeAlD
Etoposide—TOP2A—Idarubicin—Epirubicin—prostate cancer	2.2e-05	0.0284	CbGdCrCtD
Etoposide—TOP2A—Doxorubicin—Epirubicin—prostate cancer	2.2e-05	0.0284	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Epirubicin—prostate cancer	2.2e-05	0.0284	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Doxorubicin—prostate cancer	2.04e-05	0.0263	CbGdCrCtD
Etoposide—TOP2A—Epirubicin—Doxorubicin—prostate cancer	2.04e-05	0.0263	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Doxorubicin—prostate cancer	2.04e-05	0.0263	CbGdCrCtD
Etoposide—TOP2A—Norethindrone—Ethinyl Estradiol—prostate cancer	1.89e-05	0.0243	CbGdCrCtD
Etoposide—TOP2A—Levonorgestrel—Ethinyl Estradiol—prostate cancer	1.5e-05	0.0194	CbGdCrCtD
Etoposide—Loss of consciousness—Capecitabine—prostate cancer	1.33e-05	0.000277	CcSEcCtD
Etoposide—Pancytopenia—Doxorubicin—prostate cancer	1.33e-05	0.000277	CcSEcCtD
Etoposide—Renal failure—Epirubicin—prostate cancer	1.33e-05	0.000276	CcSEcCtD
Etoposide—Asthenia—Mitoxantrone—prostate cancer	1.32e-05	0.000276	CcSEcCtD
Etoposide—Neuropathy peripheral—Epirubicin—prostate cancer	1.32e-05	0.000275	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	1.32e-05	0.000275	CcSEcCtD
Etoposide—Cough—Capecitabine—prostate cancer	1.32e-05	0.000275	CcSEcCtD
Etoposide—Jaundice—Epirubicin—prostate cancer	1.32e-05	0.000274	CcSEcCtD
Etoposide—Stomatitis—Epirubicin—prostate cancer	1.32e-05	0.000274	CcSEcCtD
Etoposide—Dizziness—Estradiol—prostate cancer	1.31e-05	0.000273	CcSEcCtD
Etoposide—Neutropenia—Doxorubicin—prostate cancer	1.31e-05	0.000273	CcSEcCtD
Etoposide—Hypertension—Capecitabine—prostate cancer	1.31e-05	0.000272	CcSEcCtD
Etoposide—Chest pain—Capecitabine—prostate cancer	1.29e-05	0.000268	CcSEcCtD
Etoposide—Confusional state—Docetaxel—prostate cancer	1.29e-05	0.000268	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	1.28e-05	0.000266	CcSEcCtD
Etoposide—Hepatobiliary disease—Epirubicin—prostate cancer	1.28e-05	0.000266	CcSEcCtD
Etoposide—Anaphylactic shock—Docetaxel—prostate cancer	1.28e-05	0.000266	CcSEcCtD
Etoposide—Discomfort—Capecitabine—prostate cancer	1.27e-05	0.000265	CcSEcCtD
Etoposide—Infection—Docetaxel—prostate cancer	1.27e-05	0.000264	CcSEcCtD
Etoposide—Diarrhoea—Mitoxantrone—prostate cancer	1.26e-05	0.000263	CcSEcCtD
Etoposide—Vomiting—Estradiol—prostate cancer	1.26e-05	0.000262	CcSEcCtD
Etoposide—Agranulocytosis—Epirubicin—prostate cancer	1.26e-05	0.000262	CcSEcCtD
Etoposide—Pneumonia—Doxorubicin—prostate cancer	1.26e-05	0.000261	CcSEcCtD
Etoposide—Ill-defined disorder—Prednisone—prostate cancer	1.25e-05	0.00026	CcSEcCtD
Etoposide—Thrombocytopenia—Docetaxel—prostate cancer	1.25e-05	0.00026	CcSEcCtD
Etoposide—Rash—Estradiol—prostate cancer	1.25e-05	0.00026	CcSEcCtD
Etoposide—Infestation NOS—Doxorubicin—prostate cancer	1.25e-05	0.00026	CcSEcCtD
Etoposide—Infestation—Doxorubicin—prostate cancer	1.25e-05	0.00026	CcSEcCtD
Etoposide—Dermatitis—Estradiol—prostate cancer	1.25e-05	0.00026	CcSEcCtD
Etoposide—Anaemia—Prednisone—prostate cancer	1.25e-05	0.000259	CcSEcCtD
Etoposide—Confusional state—Capecitabine—prostate cancer	1.25e-05	0.000259	CcSEcCtD
Etoposide—Tachycardia—Docetaxel—prostate cancer	1.25e-05	0.000259	CcSEcCtD
Etoposide—Headache—Estradiol—prostate cancer	1.24e-05	0.000258	CcSEcCtD
Etoposide—Skin disorder—Docetaxel—prostate cancer	1.24e-05	0.000258	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	1.24e-05	0.000258	CcSEcCtD
Etoposide—Renal failure—Doxorubicin—prostate cancer	1.23e-05	0.000256	CcSEcCtD
Etoposide—Infection—Capecitabine—prostate cancer	1.23e-05	0.000256	CcSEcCtD
Etoposide—Neuropathy peripheral—Doxorubicin—prostate cancer	1.22e-05	0.000255	CcSEcCtD
Etoposide—Stomatitis—Doxorubicin—prostate cancer	1.22e-05	0.000253	CcSEcCtD
Etoposide—Jaundice—Doxorubicin—prostate cancer	1.22e-05	0.000253	CcSEcCtD
Etoposide—Anorexia—Docetaxel—prostate cancer	1.22e-05	0.000253	CcSEcCtD
Etoposide—Malaise—Prednisone—prostate cancer	1.22e-05	0.000253	CcSEcCtD
Etoposide—Vertigo—Prednisone—prostate cancer	1.21e-05	0.000252	CcSEcCtD
Etoposide—Thrombocytopenia—Capecitabine—prostate cancer	1.21e-05	0.000252	CcSEcCtD
Etoposide—Tachycardia—Capecitabine—prostate cancer	1.21e-05	0.000251	CcSEcCtD
Etoposide—Hypoaesthesia—Epirubicin—prostate cancer	1.21e-05	0.000251	CcSEcCtD
Etoposide—Skin disorder—Capecitabine—prostate cancer	1.2e-05	0.00025	CcSEcCtD
Etoposide—Urinary tract disorder—Epirubicin—prostate cancer	1.2e-05	0.000249	CcSEcCtD
Etoposide—Hyperhidrosis—Capecitabine—prostate cancer	1.19e-05	0.000249	CcSEcCtD
Etoposide—Hypotension—Docetaxel—prostate cancer	1.19e-05	0.000248	CcSEcCtD
Etoposide—Urethral disorder—Epirubicin—prostate cancer	1.19e-05	0.000247	CcSEcCtD
Etoposide—Loss of consciousness—Prednisone—prostate cancer	1.18e-05	0.000247	CcSEcCtD
Etoposide—Hepatobiliary disease—Doxorubicin—prostate cancer	1.18e-05	0.000246	CcSEcCtD
Etoposide—Anorexia—Capecitabine—prostate cancer	1.18e-05	0.000245	CcSEcCtD
Etoposide—Nausea—Estradiol—prostate cancer	1.18e-05	0.000245	CcSEcCtD
Etoposide—Vomiting—Mitoxantrone—prostate cancer	1.17e-05	0.000244	CcSEcCtD
Etoposide—Convulsion—Prednisone—prostate cancer	1.17e-05	0.000243	CcSEcCtD
Etoposide—Agranulocytosis—Doxorubicin—prostate cancer	1.17e-05	0.000243	CcSEcCtD
Etoposide—Hypertension—Prednisone—prostate cancer	1.16e-05	0.000242	CcSEcCtD
Etoposide—Rash—Mitoxantrone—prostate cancer	1.16e-05	0.000242	CcSEcCtD
Etoposide—Dermatitis—Mitoxantrone—prostate cancer	1.16e-05	0.000242	CcSEcCtD
Etoposide—Headache—Mitoxantrone—prostate cancer	1.16e-05	0.000241	CcSEcCtD
Etoposide—Hypotension—Capecitabine—prostate cancer	1.15e-05	0.00024	CcSEcCtD
Etoposide—Paraesthesia—Docetaxel—prostate cancer	1.15e-05	0.000239	CcSEcCtD
Etoposide—Erythema multiforme—Epirubicin—prostate cancer	1.15e-05	0.000238	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	1.14e-05	0.000237	CcSEcCtD
Etoposide—Dyspnoea—Docetaxel—prostate cancer	1.14e-05	0.000237	CcSEcCtD
Etoposide—Somnolence—Docetaxel—prostate cancer	1.13e-05	0.000236	CcSEcCtD
Etoposide—Discomfort—Prednisone—prostate cancer	1.13e-05	0.000236	CcSEcCtD
Etoposide—Eye disorder—Epirubicin—prostate cancer	1.13e-05	0.000236	CcSEcCtD
Etoposide—Cardiac disorder—Epirubicin—prostate cancer	1.12e-05	0.000234	CcSEcCtD
Etoposide—Flushing—Epirubicin—prostate cancer	1.12e-05	0.000234	CcSEcCtD
Etoposide—Hypoaesthesia—Doxorubicin—prostate cancer	1.12e-05	0.000232	CcSEcCtD
Etoposide—Paraesthesia—Capecitabine—prostate cancer	1.11e-05	0.000231	CcSEcCtD
Etoposide—Decreased appetite—Docetaxel—prostate cancer	1.11e-05	0.000231	CcSEcCtD
Etoposide—Urinary tract disorder—Doxorubicin—prostate cancer	1.11e-05	0.00023	CcSEcCtD
Etoposide—Gastrointestinal disorder—Docetaxel—prostate cancer	1.1e-05	0.000229	CcSEcCtD
Etoposide—Dyspnoea—Capecitabine—prostate cancer	1.1e-05	0.000229	CcSEcCtD
Etoposide—Anaphylactic shock—Prednisone—prostate cancer	1.1e-05	0.000229	CcSEcCtD
Etoposide—Fatigue—Docetaxel—prostate cancer	1.1e-05	0.000229	CcSEcCtD
Etoposide—Angiopathy—Epirubicin—prostate cancer	1.1e-05	0.000229	CcSEcCtD
Etoposide—Urethral disorder—Doxorubicin—prostate cancer	1.1e-05	0.000229	CcSEcCtD
Etoposide—Nausea—Mitoxantrone—prostate cancer	1.1e-05	0.000228	CcSEcCtD
Etoposide—Immune system disorder—Epirubicin—prostate cancer	1.09e-05	0.000228	CcSEcCtD
Etoposide—Infection—Prednisone—prostate cancer	1.09e-05	0.000228	CcSEcCtD
Etoposide—Mediastinal disorder—Epirubicin—prostate cancer	1.09e-05	0.000227	CcSEcCtD
Etoposide—Constipation—Docetaxel—prostate cancer	1.09e-05	0.000227	CcSEcCtD
Etoposide—Pain—Docetaxel—prostate cancer	1.09e-05	0.000227	CcSEcCtD
Etoposide—Chills—Epirubicin—prostate cancer	1.09e-05	0.000226	CcSEcCtD
Etoposide—Tachycardia—Prednisone—prostate cancer	1.07e-05	0.000224	CcSEcCtD
Etoposide—Decreased appetite—Capecitabine—prostate cancer	1.07e-05	0.000224	CcSEcCtD
Etoposide—Alopecia—Epirubicin—prostate cancer	1.07e-05	0.000223	CcSEcCtD
Etoposide—Skin disorder—Prednisone—prostate cancer	1.07e-05	0.000223	CcSEcCtD
Etoposide—Gastrointestinal disorder—Capecitabine—prostate cancer	1.07e-05	0.000222	CcSEcCtD
Etoposide—Fatigue—Capecitabine—prostate cancer	1.06e-05	0.000222	CcSEcCtD
Etoposide—Hyperhidrosis—Prednisone—prostate cancer	1.06e-05	0.000221	CcSEcCtD
Etoposide—Erythema multiforme—Doxorubicin—prostate cancer	1.06e-05	0.000221	CcSEcCtD
Etoposide—Pain—Capecitabine—prostate cancer	1.06e-05	0.00022	CcSEcCtD
Etoposide—Constipation—Capecitabine—prostate cancer	1.06e-05	0.00022	CcSEcCtD
Etoposide—Feeling abnormal—Docetaxel—prostate cancer	1.05e-05	0.000219	CcSEcCtD
Etoposide—Anorexia—Prednisone—prostate cancer	1.05e-05	0.000218	CcSEcCtD
Etoposide—Eye disorder—Doxorubicin—prostate cancer	1.05e-05	0.000218	CcSEcCtD
Etoposide—Gastrointestinal pain—Docetaxel—prostate cancer	1.04e-05	0.000217	CcSEcCtD
Etoposide—Flushing—Doxorubicin—prostate cancer	1.04e-05	0.000217	CcSEcCtD
Etoposide—Cardiac disorder—Doxorubicin—prostate cancer	1.04e-05	0.000217	CcSEcCtD
Etoposide—Dysgeusia—Epirubicin—prostate cancer	1.03e-05	0.000215	CcSEcCtD
Etoposide—Back pain—Epirubicin—prostate cancer	1.02e-05	0.000212	CcSEcCtD
Etoposide—Feeling abnormal—Capecitabine—prostate cancer	1.02e-05	0.000212	CcSEcCtD
Etoposide—Angiopathy—Doxorubicin—prostate cancer	1.02e-05	0.000212	CcSEcCtD
Etoposide—TOP2A—Methyltestosterone—Prednisone—prostate cancer	1.02e-05	0.0131	CbGdCrCtD
Etoposide—Muscle spasms—Epirubicin—prostate cancer	1.01e-05	0.000211	CcSEcCtD
Etoposide—Immune system disorder—Doxorubicin—prostate cancer	1.01e-05	0.000211	CcSEcCtD
Etoposide—Gastrointestinal pain—Capecitabine—prostate cancer	1.01e-05	0.00021	CcSEcCtD
Etoposide—Mediastinal disorder—Doxorubicin—prostate cancer	1.01e-05	0.00021	CcSEcCtD
Etoposide—Abdominal pain—Docetaxel—prostate cancer	1.01e-05	0.00021	CcSEcCtD
Etoposide—Body temperature increased—Docetaxel—prostate cancer	1.01e-05	0.00021	CcSEcCtD
Etoposide—Chills—Doxorubicin—prostate cancer	1.01e-05	0.000209	CcSEcCtD
Etoposide—Alopecia—Doxorubicin—prostate cancer	9.9e-06	0.000206	CcSEcCtD
Etoposide—Paraesthesia—Prednisone—prostate cancer	9.88e-06	0.000206	CcSEcCtD
Etoposide—Urticaria—Capecitabine—prostate cancer	9.81e-06	0.000204	CcSEcCtD
Etoposide—Ill-defined disorder—Epirubicin—prostate cancer	9.78e-06	0.000204	CcSEcCtD
Etoposide—Abdominal pain—Capecitabine—prostate cancer	9.76e-06	0.000203	CcSEcCtD
Etoposide—Body temperature increased—Capecitabine—prostate cancer	9.76e-06	0.000203	CcSEcCtD
Etoposide—Anaemia—Epirubicin—prostate cancer	9.75e-06	0.000203	CcSEcCtD
Etoposide—Decreased appetite—Prednisone—prostate cancer	9.56e-06	0.000199	CcSEcCtD
Etoposide—Dysgeusia—Doxorubicin—prostate cancer	9.55e-06	0.000199	CcSEcCtD
Etoposide—Malaise—Epirubicin—prostate cancer	9.51e-06	0.000198	CcSEcCtD
Etoposide—Fatigue—Prednisone—prostate cancer	9.49e-06	0.000198	CcSEcCtD
Etoposide—Vertigo—Epirubicin—prostate cancer	9.47e-06	0.000197	CcSEcCtD
Etoposide—Leukopenia—Epirubicin—prostate cancer	9.44e-06	0.000197	CcSEcCtD
Etoposide—Back pain—Doxorubicin—prostate cancer	9.44e-06	0.000196	CcSEcCtD
Etoposide—Constipation—Prednisone—prostate cancer	9.41e-06	0.000196	CcSEcCtD
Etoposide—Hypersensitivity—Docetaxel—prostate cancer	9.4e-06	0.000196	CcSEcCtD
Etoposide—Muscle spasms—Doxorubicin—prostate cancer	9.38e-06	0.000195	CcSEcCtD
Etoposide—Loss of consciousness—Epirubicin—prostate cancer	9.27e-06	0.000193	CcSEcCtD
Etoposide—Cough—Epirubicin—prostate cancer	9.2e-06	0.000192	CcSEcCtD
Etoposide—Asthenia—Docetaxel—prostate cancer	9.15e-06	0.000191	CcSEcCtD
Etoposide—Convulsion—Epirubicin—prostate cancer	9.14e-06	0.00019	CcSEcCtD
Etoposide—Hypertension—Epirubicin—prostate cancer	9.1e-06	0.00019	CcSEcCtD
Etoposide—Hypersensitivity—Capecitabine—prostate cancer	9.1e-06	0.000189	CcSEcCtD
Etoposide—Feeling abnormal—Prednisone—prostate cancer	9.07e-06	0.000189	CcSEcCtD
Etoposide—Ill-defined disorder—Doxorubicin—prostate cancer	9.05e-06	0.000188	CcSEcCtD
Etoposide—Pruritus—Docetaxel—prostate cancer	9.03e-06	0.000188	CcSEcCtD
Etoposide—Anaemia—Doxorubicin—prostate cancer	9.02e-06	0.000188	CcSEcCtD
Etoposide—Gastrointestinal pain—Prednisone—prostate cancer	9e-06	0.000187	CcSEcCtD
Etoposide—Chest pain—Epirubicin—prostate cancer	8.98e-06	0.000187	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	8.91e-06	0.000186	CcSEcCtD
Etoposide—Discomfort—Epirubicin—prostate cancer	8.87e-06	0.000185	CcSEcCtD
Etoposide—Asthenia—Capecitabine—prostate cancer	8.86e-06	0.000185	CcSEcCtD
Etoposide—Malaise—Doxorubicin—prostate cancer	8.8e-06	0.000183	CcSEcCtD
Etoposide—Vertigo—Doxorubicin—prostate cancer	8.77e-06	0.000183	CcSEcCtD
Etoposide—Urticaria—Prednisone—prostate cancer	8.74e-06	0.000182	CcSEcCtD
Etoposide—Pruritus—Capecitabine—prostate cancer	8.74e-06	0.000182	CcSEcCtD
Etoposide—Leukopenia—Doxorubicin—prostate cancer	8.73e-06	0.000182	CcSEcCtD
Etoposide—Diarrhoea—Docetaxel—prostate cancer	8.73e-06	0.000182	CcSEcCtD
Etoposide—Body temperature increased—Prednisone—prostate cancer	8.7e-06	0.000181	CcSEcCtD
Etoposide—Abdominal pain—Prednisone—prostate cancer	8.7e-06	0.000181	CcSEcCtD
Etoposide—Confusional state—Epirubicin—prostate cancer	8.68e-06	0.000181	CcSEcCtD
Etoposide—Anaphylactic shock—Epirubicin—prostate cancer	8.61e-06	0.000179	CcSEcCtD
Etoposide—Loss of consciousness—Doxorubicin—prostate cancer	8.57e-06	0.000179	CcSEcCtD
Etoposide—Infection—Epirubicin—prostate cancer	8.55e-06	0.000178	CcSEcCtD
Etoposide—Cough—Doxorubicin—prostate cancer	8.51e-06	0.000177	CcSEcCtD
Etoposide—Convulsion—Doxorubicin—prostate cancer	8.45e-06	0.000176	CcSEcCtD
Etoposide—Diarrhoea—Capecitabine—prostate cancer	8.45e-06	0.000176	CcSEcCtD
Etoposide—Dizziness—Docetaxel—prostate cancer	8.44e-06	0.000176	CcSEcCtD
Etoposide—Thrombocytopenia—Epirubicin—prostate cancer	8.43e-06	0.000175	CcSEcCtD
Etoposide—Hypertension—Doxorubicin—prostate cancer	8.42e-06	0.000175	CcSEcCtD
Etoposide—Tachycardia—Epirubicin—prostate cancer	8.4e-06	0.000175	CcSEcCtD
Etoposide—Skin disorder—Epirubicin—prostate cancer	8.36e-06	0.000174	CcSEcCtD
Etoposide—Hyperhidrosis—Epirubicin—prostate cancer	8.32e-06	0.000173	CcSEcCtD
Etoposide—Chest pain—Doxorubicin—prostate cancer	8.31e-06	0.000173	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	8.25e-06	0.000172	CcSEcCtD
Etoposide—Discomfort—Doxorubicin—prostate cancer	8.21e-06	0.000171	CcSEcCtD
Etoposide—Anorexia—Epirubicin—prostate cancer	8.2e-06	0.000171	CcSEcCtD
Etoposide—Dizziness—Capecitabine—prostate cancer	8.17e-06	0.00017	CcSEcCtD
Etoposide—Vomiting—Docetaxel—prostate cancer	8.11e-06	0.000169	CcSEcCtD
Etoposide—Hypersensitivity—Prednisone—prostate cancer	8.11e-06	0.000169	CcSEcCtD
Etoposide—Rash—Docetaxel—prostate cancer	8.04e-06	0.000167	CcSEcCtD
Etoposide—Hypotension—Epirubicin—prostate cancer	8.04e-06	0.000167	CcSEcCtD
Etoposide—Dermatitis—Docetaxel—prostate cancer	8.04e-06	0.000167	CcSEcCtD
Etoposide—Confusional state—Doxorubicin—prostate cancer	8.03e-06	0.000167	CcSEcCtD
Etoposide—Headache—Docetaxel—prostate cancer	7.99e-06	0.000166	CcSEcCtD
Etoposide—Anaphylactic shock—Doxorubicin—prostate cancer	7.96e-06	0.000166	CcSEcCtD
Etoposide—Infection—Doxorubicin—prostate cancer	7.91e-06	0.000165	CcSEcCtD
Etoposide—Asthenia—Prednisone—prostate cancer	7.89e-06	0.000164	CcSEcCtD
Etoposide—Vomiting—Capecitabine—prostate cancer	7.85e-06	0.000164	CcSEcCtD
Etoposide—Thrombocytopenia—Doxorubicin—prostate cancer	7.8e-06	0.000162	CcSEcCtD
Etoposide—Rash—Capecitabine—prostate cancer	7.79e-06	0.000162	CcSEcCtD
Etoposide—Pruritus—Prednisone—prostate cancer	7.78e-06	0.000162	CcSEcCtD
Etoposide—Dermatitis—Capecitabine—prostate cancer	7.78e-06	0.000162	CcSEcCtD
Etoposide—Tachycardia—Doxorubicin—prostate cancer	7.77e-06	0.000162	CcSEcCtD
Etoposide—Headache—Capecitabine—prostate cancer	7.74e-06	0.000161	CcSEcCtD
Etoposide—Skin disorder—Doxorubicin—prostate cancer	7.73e-06	0.000161	CcSEcCtD
Etoposide—Paraesthesia—Epirubicin—prostate cancer	7.73e-06	0.000161	CcSEcCtD
Etoposide—Hyperhidrosis—Doxorubicin—prostate cancer	7.7e-06	0.00016	CcSEcCtD
Etoposide—Dyspnoea—Epirubicin—prostate cancer	7.67e-06	0.00016	CcSEcCtD
Etoposide—Somnolence—Epirubicin—prostate cancer	7.65e-06	0.000159	CcSEcCtD
Etoposide—Anorexia—Doxorubicin—prostate cancer	7.59e-06	0.000158	CcSEcCtD
Etoposide—Nausea—Docetaxel—prostate cancer	7.58e-06	0.000158	CcSEcCtD
Etoposide—Diarrhoea—Prednisone—prostate cancer	7.53e-06	0.000157	CcSEcCtD
Etoposide—Decreased appetite—Epirubicin—prostate cancer	7.48e-06	0.000156	CcSEcCtD
Etoposide—Hypotension—Doxorubicin—prostate cancer	7.44e-06	0.000155	CcSEcCtD
Etoposide—Gastrointestinal disorder—Epirubicin—prostate cancer	7.43e-06	0.000155	CcSEcCtD
Etoposide—Fatigue—Epirubicin—prostate cancer	7.42e-06	0.000154	CcSEcCtD
Etoposide—Constipation—Epirubicin—prostate cancer	7.36e-06	0.000153	CcSEcCtD
Etoposide—Pain—Epirubicin—prostate cancer	7.36e-06	0.000153	CcSEcCtD
Etoposide—Nausea—Capecitabine—prostate cancer	7.34e-06	0.000153	CcSEcCtD
Etoposide—Dizziness—Prednisone—prostate cancer	7.28e-06	0.000151	CcSEcCtD
Etoposide—Paraesthesia—Doxorubicin—prostate cancer	7.15e-06	0.000149	CcSEcCtD
Etoposide—Dyspnoea—Doxorubicin—prostate cancer	7.1e-06	0.000148	CcSEcCtD
Etoposide—Feeling abnormal—Epirubicin—prostate cancer	7.09e-06	0.000148	CcSEcCtD
Etoposide—Somnolence—Doxorubicin—prostate cancer	7.08e-06	0.000147	CcSEcCtD
Etoposide—Gastrointestinal pain—Epirubicin—prostate cancer	7.04e-06	0.000147	CcSEcCtD
Etoposide—Vomiting—Prednisone—prostate cancer	7e-06	0.000146	CcSEcCtD
Etoposide—Rash—Prednisone—prostate cancer	6.94e-06	0.000144	CcSEcCtD
Etoposide—Dermatitis—Prednisone—prostate cancer	6.93e-06	0.000144	CcSEcCtD
Etoposide—Decreased appetite—Doxorubicin—prostate cancer	6.92e-06	0.000144	CcSEcCtD
Etoposide—Headache—Prednisone—prostate cancer	6.89e-06	0.000144	CcSEcCtD
Etoposide—Gastrointestinal disorder—Doxorubicin—prostate cancer	6.87e-06	0.000143	CcSEcCtD
Etoposide—Fatigue—Doxorubicin—prostate cancer	6.86e-06	0.000143	CcSEcCtD
Etoposide—Urticaria—Epirubicin—prostate cancer	6.84e-06	0.000142	CcSEcCtD
Etoposide—Constipation—Doxorubicin—prostate cancer	6.81e-06	0.000142	CcSEcCtD
Etoposide—Pain—Doxorubicin—prostate cancer	6.81e-06	0.000142	CcSEcCtD
Etoposide—Abdominal pain—Epirubicin—prostate cancer	6.8e-06	0.000142	CcSEcCtD
Etoposide—Body temperature increased—Epirubicin—prostate cancer	6.8e-06	0.000142	CcSEcCtD
Etoposide—Feeling abnormal—Doxorubicin—prostate cancer	6.56e-06	0.000137	CcSEcCtD
Etoposide—Nausea—Prednisone—prostate cancer	6.54e-06	0.000136	CcSEcCtD
Etoposide—Gastrointestinal pain—Doxorubicin—prostate cancer	6.51e-06	0.000136	CcSEcCtD
Etoposide—Hypersensitivity—Epirubicin—prostate cancer	6.34e-06	0.000132	CcSEcCtD
Etoposide—Urticaria—Doxorubicin—prostate cancer	6.33e-06	0.000132	CcSEcCtD
Etoposide—Abdominal pain—Doxorubicin—prostate cancer	6.29e-06	0.000131	CcSEcCtD
Etoposide—Body temperature increased—Doxorubicin—prostate cancer	6.29e-06	0.000131	CcSEcCtD
Etoposide—Asthenia—Epirubicin—prostate cancer	6.17e-06	0.000129	CcSEcCtD
Etoposide—Pruritus—Epirubicin—prostate cancer	6.09e-06	0.000127	CcSEcCtD
Etoposide—Diarrhoea—Epirubicin—prostate cancer	5.89e-06	0.000123	CcSEcCtD
Etoposide—Hypersensitivity—Doxorubicin—prostate cancer	5.87e-06	0.000122	CcSEcCtD
Etoposide—Asthenia—Doxorubicin—prostate cancer	5.71e-06	0.000119	CcSEcCtD
Etoposide—Dizziness—Epirubicin—prostate cancer	5.69e-06	0.000118	CcSEcCtD
Etoposide—Pruritus—Doxorubicin—prostate cancer	5.63e-06	0.000117	CcSEcCtD
Etoposide—Vomiting—Epirubicin—prostate cancer	5.47e-06	0.000114	CcSEcCtD
Etoposide—Diarrhoea—Doxorubicin—prostate cancer	5.45e-06	0.000113	CcSEcCtD
Etoposide—Rash—Epirubicin—prostate cancer	5.43e-06	0.000113	CcSEcCtD
Etoposide—Dermatitis—Epirubicin—prostate cancer	5.42e-06	0.000113	CcSEcCtD
Etoposide—Headache—Epirubicin—prostate cancer	5.39e-06	0.000112	CcSEcCtD
Etoposide—Dizziness—Doxorubicin—prostate cancer	5.27e-06	0.00011	CcSEcCtD
Etoposide—Nausea—Epirubicin—prostate cancer	5.11e-06	0.000106	CcSEcCtD
Etoposide—Vomiting—Doxorubicin—prostate cancer	5.06e-06	0.000105	CcSEcCtD
Etoposide—Rash—Doxorubicin—prostate cancer	5.02e-06	0.000105	CcSEcCtD
Etoposide—Dermatitis—Doxorubicin—prostate cancer	5.02e-06	0.000104	CcSEcCtD
Etoposide—Headache—Doxorubicin—prostate cancer	4.99e-06	0.000104	CcSEcCtD
Etoposide—Nausea—Doxorubicin—prostate cancer	4.73e-06	9.85e-05	CcSEcCtD
Etoposide—PTGS2—Disease—EGF—prostate cancer	5.04e-07	1.34e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.03e-07	1.34e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTEN—prostate cancer	5.03e-07	1.34e-05	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AKT1—prostate cancer	5.02e-07	1.33e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ITPR1—prostate cancer	5.01e-07	1.33e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTGS2—prostate cancer	5.01e-07	1.33e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CREBBP—prostate cancer	4.99e-07	1.33e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PPARA—prostate cancer	4.99e-07	1.32e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GGT1—prostate cancer	4.94e-07	1.31e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.93e-07	1.31e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CD—prostate cancer	4.92e-07	1.31e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKR1C3—prostate cancer	4.91e-07	1.31e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—GSK3B—prostate cancer	4.89e-07	1.3e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PRKACB—prostate cancer	4.89e-07	1.3e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CB—prostate cancer	4.88e-07	1.3e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.88e-07	1.3e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PLCB2—prostate cancer	4.88e-07	1.3e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—LRP2—prostate cancer	4.88e-07	1.3e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NCOA1—prostate cancer	4.87e-07	1.29e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP17A1—prostate cancer	4.84e-07	1.29e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTGS2—prostate cancer	4.83e-07	1.28e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—INS—prostate cancer	4.83e-07	1.28e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—EP300—prostate cancer	4.8e-07	1.27e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP19A1—prostate cancer	4.8e-07	1.27e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—MTHFR—prostate cancer	4.79e-07	1.27e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—P4HB—prostate cancer	4.78e-07	1.27e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—MTHFR—prostate cancer	4.78e-07	1.27e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.77e-07	1.27e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—TYMS—prostate cancer	4.73e-07	1.26e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CD—prostate cancer	4.73e-07	1.26e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CREBBP—prostate cancer	4.73e-07	1.26e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PPARA—prostate cancer	4.69e-07	1.25e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CAV1—prostate cancer	4.69e-07	1.25e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PPARA—prostate cancer	4.69e-07	1.24e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTM1—prostate cancer	4.68e-07	1.24e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—SRC—prostate cancer	4.67e-07	1.24e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.65e-07	1.24e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—NOS3—prostate cancer	4.65e-07	1.23e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—RXRA—prostate cancer	4.63e-07	1.23e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NCOA2—prostate cancer	4.61e-07	1.22e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—LPL—prostate cancer	4.59e-07	1.22e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.53e-07	1.2e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAP2K1—prostate cancer	4.51e-07	1.2e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—STAT3—prostate cancer	4.5e-07	1.2e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CD—prostate cancer	4.48e-07	1.19e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.48e-07	1.19e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—NOS3—prostate cancer	4.47e-07	1.19e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—MED12—prostate cancer	4.46e-07	1.18e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—COMT—prostate cancer	4.46e-07	1.18e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTP1—prostate cancer	4.44e-07	1.18e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP1A1—prostate cancer	4.44e-07	1.18e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—SERPINE1—prostate cancer	4.43e-07	1.18e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GNG5—prostate cancer	4.43e-07	1.18e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CAV1—prostate cancer	4.41e-07	1.17e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CAV1—prostate cancer	4.41e-07	1.17e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ERCC2—prostate cancer	4.4e-07	1.17e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SLC5A5—prostate cancer	4.4e-07	1.17e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTEN—prostate cancer	4.37e-07	1.16e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ITPR1—prostate cancer	4.37e-07	1.16e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP2E1—prostate cancer	4.3e-07	1.14e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—FGF2—prostate cancer	4.29e-07	1.14e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CB—prostate cancer	4.29e-07	1.14e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CG—prostate cancer	4.27e-07	1.13e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NCOA3—prostate cancer	4.26e-07	1.13e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTGS2—prostate cancer	4.25e-07	1.13e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NQO1—prostate cancer	4.25e-07	1.13e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NOS3—prostate cancer	4.23e-07	1.12e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTEN—prostate cancer	4.21e-07	1.12e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—TH—prostate cancer	4.19e-07	1.11e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MYC—prostate cancer	4.18e-07	1.11e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—TGFB1—prostate cancer	4.17e-07	1.11e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—EP300—prostate cancer	4.17e-07	1.11e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.16e-07	1.1e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP3A4—prostate cancer	4.14e-07	1.1e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—MTHFR—prostate cancer	4.14e-07	1.1e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—TYMS—prostate cancer	4.13e-07	1.1e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CB—prostate cancer	4.12e-07	1.1e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.12e-07	1.09e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—JAK2—prostate cancer	4.11e-07	1.09e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—EGFR—prostate cancer	4.09e-07	1.09e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTGS2—prostate cancer	4.08e-07	1.09e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTM1—prostate cancer	4.08e-07	1.08e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP1B1—prostate cancer	4.07e-07	1.08e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HPGDS—prostate cancer	4.07e-07	1.08e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PPARA—prostate cancer	4.06e-07	1.08e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—INS—prostate cancer	4.04e-07	1.07e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.04e-07	1.07e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CG—prostate cancer	4.02e-07	1.07e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—EP300—prostate cancer	4.02e-07	1.07e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MDM2—prostate cancer	4.02e-07	1.07e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CG—prostate cancer	4.01e-07	1.07e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—LPL—prostate cancer	4e-07	1.06e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CREBBP—prostate cancer	3.96e-07	1.05e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—ERBB2—prostate cancer	3.96e-07	1.05e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ACHE—prostate cancer	3.94e-07	1.05e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTT1—prostate cancer	3.94e-07	1.05e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GGT1—prostate cancer	3.94e-07	1.05e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CB—prostate cancer	3.91e-07	1.04e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.9e-07	1.04e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NCOA1—prostate cancer	3.88e-07	1.03e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP1A1—prostate cancer	3.87e-07	1.03e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—KRAS—prostate cancer	3.86e-07	1.03e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ERCC2—prostate cancer	3.83e-07	1.02e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP19A1—prostate cancer	3.83e-07	1.02e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CAV1—prostate cancer	3.82e-07	1.01e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—INS—prostate cancer	3.81e-07	1.01e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—INS—prostate cancer	3.8e-07	1.01e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CA—prostate cancer	3.79e-07	1.01e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.79e-07	1.01e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PRKACB—prostate cancer	3.77e-07	1e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CD—prostate cancer	3.75e-07	9.97e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.73e-07	9.92e-06	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CREBBP—prostate cancer	3.73e-07	9.9e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CREBBP—prostate cancer	3.72e-07	9.88e-06	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTEN—prostate cancer	3.71e-07	9.85e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—RXRA—prostate cancer	3.69e-07	9.81e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1B—prostate cancer	3.67e-07	9.74e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.65e-07	9.68e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—MTHFR—prostate cancer	3.6e-07	9.57e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.59e-07	9.55e-06	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTEN—prostate cancer	3.56e-07	9.46e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—COMT—prostate cancer	3.56e-07	9.45e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NCOA2—prostate cancer	3.56e-07	9.45e-06	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CA—prostate cancer	3.55e-07	9.43e-06	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—NOS3—prostate cancer	3.55e-07	9.42e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTP1—prostate cancer	3.54e-07	9.41e-06	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—EP300—prostate cancer	3.54e-07	9.39e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PPARA—prostate cancer	3.54e-07	9.39e-06	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CD—prostate cancer	3.53e-07	9.39e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CD—prostate cancer	3.53e-07	9.37e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ITPR1—prostate cancer	3.49e-07	9.26e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CG—prostate cancer	3.48e-07	9.23e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—CTNNB1—prostate cancer	3.46e-07	9.2e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.43e-07	9.1e-06	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—EP300—prostate cancer	3.4e-07	9.02e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.39e-07	9.02e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1A—prostate cancer	3.38e-07	8.99e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—PTEN—prostate cancer	3.38e-07	8.97e-06	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—NOS3—prostate cancer	3.34e-07	8.87e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—NOS3—prostate cancer	3.33e-07	8.85e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CAV1—prostate cancer	3.32e-07	8.83e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.31e-07	8.81e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—TYMS—prostate cancer	3.29e-07	8.75e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—INS—prostate cancer	3.29e-07	8.74e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NQO1—prostate cancer	3.28e-07	8.71e-06	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CB—prostate cancer	3.27e-07	8.69e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTM1—prostate cancer	3.26e-07	8.65e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—TH—prostate cancer	3.23e-07	8.58e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CREBBP—prostate cancer	3.22e-07	8.56e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—EP300—prostate cancer	3.22e-07	8.55e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—LPL—prostate cancer	3.2e-07	8.49e-06	CbGpPWpGaD
Etoposide—ABCC1—Disease—IL6—prostate cancer	3.14e-07	8.35e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.14e-07	8.35e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—SRC—prostate cancer	3.13e-07	8.32e-06	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AKT1—prostate cancer	3.1e-07	8.23e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP1A1—prostate cancer	3.09e-07	8.2e-06	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CA—prostate cancer	3.08e-07	8.19e-06	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CB—prostate cancer	3.08e-07	8.18e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CB—prostate cancer	3.07e-07	8.17e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ERCC2—prostate cancer	3.06e-07	8.13e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CD—prostate cancer	3.06e-07	8.12e-06	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS2—prostate cancer	3.05e-07	8.11e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS2—prostate cancer	3.05e-07	8.09e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GGT1—prostate cancer	3.04e-07	8.08e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CG—prostate cancer	3.03e-07	8.04e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—STAT3—prostate cancer	3.02e-07	8.02e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NCOA1—prostate cancer	3e-07	7.96e-06	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CA—prostate cancer	2.97e-07	7.9e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.95e-07	7.85e-06	CbGpPWpGaD
Etoposide—ABCC1—Disease—AKT1—prostate cancer	2.9e-07	7.7e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—NOS3—prostate cancer	2.88e-07	7.66e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—MTHFR—prostate cancer	2.88e-07	7.64e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—INS—prostate cancer	2.87e-07	7.61e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—RXRA—prostate cancer	2.85e-07	7.57e-06	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PTEN—prostate cancer	2.83e-07	7.51e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PPARA—prostate cancer	2.82e-07	7.5e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CREBBP—prostate cancer	2.81e-07	7.46e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—MYC—prostate cancer	2.81e-07	7.45e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—TGFB1—prostate cancer	2.8e-07	7.44e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—COMT—prostate cancer	2.75e-07	7.3e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGFR—prostate cancer	2.74e-07	7.29e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTP1—prostate cancer	2.73e-07	7.26e-06	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—EP300—prostate cancer	2.7e-07	7.16e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ITPR1—prostate cancer	2.69e-07	7.15e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CB—prostate cancer	2.66e-07	7.07e-06	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTEN—prostate cancer	2.66e-07	7.07e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CD—prostate cancer	2.66e-07	7.07e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTEN—prostate cancer	2.66e-07	7.06e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CAV1—prostate cancer	2.65e-07	7.05e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS2—prostate cancer	2.64e-07	7.01e-06	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CA—prostate cancer	2.62e-07	6.95e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—KRAS—prostate cancer	2.59e-07	6.89e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—TYMS—prostate cancer	2.54e-07	6.75e-06	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—EP300—prostate cancer	2.54e-07	6.74e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.54e-07	6.73e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—EP300—prostate cancer	2.53e-07	6.73e-06	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKT1—prostate cancer	2.52e-07	6.69e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NOS3—prostate cancer	2.51e-07	6.68e-06	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CA—prostate cancer	2.51e-07	6.68e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTM1—prostate cancer	2.51e-07	6.67e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—LPL—prostate cancer	2.47e-07	6.55e-06	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKT1—prostate cancer	2.43e-07	6.45e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.42e-07	6.42e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CA—prostate cancer	2.38e-07	6.33e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.38e-07	6.33e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ERCC2—prostate cancer	2.36e-07	6.27e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CB—prostate cancer	2.32e-07	6.16e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTEN—prostate cancer	2.3e-07	6.11e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS2—prostate cancer	2.3e-07	6.11e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—INS—prostate cancer	2.29e-07	6.08e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CREBBP—prostate cancer	2.24e-07	5.95e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—MTHFR—prostate cancer	2.22e-07	5.9e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—EP300—prostate cancer	2.19e-07	5.83e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PPARA—prostate cancer	2.18e-07	5.79e-06	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKT1—prostate cancer	2.14e-07	5.68e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.12e-07	5.64e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6—prostate cancer	2.11e-07	5.6e-06	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKT1—prostate cancer	2.05e-07	5.45e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CAV1—prostate cancer	2.05e-07	5.44e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NOS3—prostate cancer	2.01e-07	5.33e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTEN—prostate cancer	2e-07	5.33e-06	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CA—prostate cancer	2e-07	5.3e-06	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT1—prostate cancer	1.95e-07	5.17e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—EP300—prostate cancer	1.91e-07	5.08e-06	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CA—prostate cancer	1.88e-07	4.99e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.87e-07	4.98e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.87e-07	4.96e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.85e-07	4.92e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS2—prostate cancer	1.84e-07	4.87e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—INS—prostate cancer	1.77e-07	4.69e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CREBBP—prostate cancer	1.73e-07	4.59e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.64e-07	4.36e-06	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKT1—prostate cancer	1.63e-07	4.33e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.62e-07	4.31e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTEN—prostate cancer	1.6e-07	4.25e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NOS3—prostate cancer	1.55e-07	4.11e-06	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKT1—prostate cancer	1.53e-07	4.08e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKT1—prostate cancer	1.53e-07	4.07e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—EP300—prostate cancer	1.53e-07	4.05e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.43e-07	3.8e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS2—prostate cancer	1.42e-07	3.76e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CA—prostate cancer	1.41e-07	3.76e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKT1—prostate cancer	1.33e-07	3.52e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTEN—prostate cancer	1.24e-07	3.28e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—EP300—prostate cancer	1.18e-07	3.13e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKT1—prostate cancer	1.16e-07	3.07e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.13e-07	3e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKT1—prostate cancer	9.22e-08	2.45e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CA—prostate cancer	8.71e-08	2.31e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKT1—prostate cancer	7.12e-08	1.89e-06	CbGpPWpGaD
